Expanded Access Programme for the use of tecovirimat for the treatment of monkeypox infection: a study protocol for an Expanded Access Programme
View ORCID ProfileJosephine Bourner, Festus Devincy Redji Mbrenga, View ORCID ProfileChristian Noël Malaka, Jake Dunning, Amanda Rojek, Emmanuel Fandema, Peter Horby, Yap Boum II, Emmanuel Nakouné, View ORCID ProfilePiero Olliaro
doi: https://doi.org/10.1101/2022.11.28.22282846
Josephine Bourner
1Pandemic Sciences Institute, University of Oxford, United Kingdom
Festus Devincy Redji Mbrenga
2Institut Pasteur de Bangui, Central African Republic
Christian Noël Malaka
2Institut Pasteur de Bangui, Central African Republic
Jake Dunning
1Pandemic Sciences Institute, University of Oxford, United Kingdom
Amanda Rojek
1Pandemic Sciences Institute, University of Oxford, United Kingdom
Emmanuel Fandema
3Ministry of Health, Central African Republic
Peter Horby
1Pandemic Sciences Institute, University of Oxford, United Kingdom
Yap Boum II
2Institut Pasteur de Bangui, Central African Republic
Emmanuel Nakouné
2Institut Pasteur de Bangui, Central African Republic
Piero Olliaro
1Pandemic Sciences Institute, University of Oxford, United Kingdom
Data Availability
No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.
Posted November 29, 2022.
Expanded Access Programme for the use of tecovirimat for the treatment of monkeypox infection: a study protocol for an Expanded Access Programme
Josephine Bourner, Festus Devincy Redji Mbrenga, Christian Noël Malaka, Jake Dunning, Amanda Rojek, Emmanuel Fandema, Peter Horby, Yap Boum II, Emmanuel Nakouné, Piero Olliaro
medRxiv 2022.11.28.22282846; doi: https://doi.org/10.1101/2022.11.28.22282846
Expanded Access Programme for the use of tecovirimat for the treatment of monkeypox infection: a study protocol for an Expanded Access Programme
Josephine Bourner, Festus Devincy Redji Mbrenga, Christian Noël Malaka, Jake Dunning, Amanda Rojek, Emmanuel Fandema, Peter Horby, Yap Boum II, Emmanuel Nakouné, Piero Olliaro
medRxiv 2022.11.28.22282846; doi: https://doi.org/10.1101/2022.11.28.22282846
Subject Area
Subject Areas
- Addiction Medicine (362)
- Allergy and Immunology (683)
- Anesthesia (183)
- Cardiovascular Medicine (2722)
- Dermatology (234)
- Emergency Medicine (411)
- Epidemiology (12370)
- Forensic Medicine (10)
- Gastroenterology (782)
- Genetic and Genomic Medicine (4223)
- Geriatric Medicine (394)
- Health Economics (697)
- Health Informatics (2725)
- Health Policy (1013)
- Hematology (369)
- HIV/AIDS (873)
- Medical Education (404)
- Medical Ethics (111)
- Nephrology (450)
- Neurology (4001)
- Nursing (216)
- Nutrition (592)
- Oncology (2110)
- Ophthalmology (602)
- Orthopedics (250)
- Otolaryngology (309)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (475)
- Pediatrics (1143)
- Primary Care Research (465)
- Public and Global Health (6626)
- Radiology and Imaging (1439)
- Respiratory Medicine (882)
- Rheumatology (418)
- Sports Medicine (350)
- Surgery (460)
- Toxicology (57)
- Transplantation (192)
- Urology (171)